Riskpilot← Back to searchSign inGet full accessLivio Sperm Bank ApS
APSActiveCVR 42748552Vestergade 16, st.Other human health activities n.e.c. · NACE 8699Est. 20211 employees
Revenue 2024
DKK 2,4M
+102% vs 2023
EBITDA margin
13.7%
+65% vs 2023
Equity ratio
-60.4%
Financial strength
Net profit 2024
DKK 97K
+159% vs 2023
| Revenue | DKK 2,4M | +102% |
| EBITDA | DKK 328K | +65% |
| Net profit | DKK 97K | +159% |
| Total assets | DKK 1,6M | +23% |
| Equity | DKK -949K | +9% |
| Employees | 1 | — |
Legal name
Livio Sperm Bank ApS
CVR number
42748552
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
1. oktober 2021
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et medlem af bestyrelsen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive forretning inden for rekruttering af sæddonorer med efterfølgende salg af bearbejdet sæd. Formålet er at bidrage til det store behov af donorsæd blandt ufrivillig barnløse i Norden med det mål at ekspandere globalt.
Address
Vestergade 16, st.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -509 | 1.187 | 2.399 |
| Staff expenses | -664 | -988 | -2.071 |
| EBITDA | -1.173 | 199 | 328 |
| Depreciation & amort. | -25 | -39 | -47 |
| EBIT | -1.199 | 160 | 281 |
| Net financials | 20 | -67 | -184 |
| Profit before tax | -1.179 | 93 | 97 |
| Tax | -258 | 258 | -0 |
| Net profit | -921 | -165 | 97 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 578 | 1.283 | 1.572 |
| Equity | -881 | -1.046 | -949 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 1.458 | 2.329 | 2.521 |
| Total debt | 1.458 | 2.329 | 2.521 |
EBITDA margin
13.7%
This company
15.8%
Market median
-13% vs market
20222024
Equity ratio
-60.4%
This company
38.2%
Market median
-258% vs market
20222024
Return on equity
9705400.0%
This company
18.4%
Market median
+52746639% vs market
20222024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20222024
Asset turnover
1.53×
This company
1.12×
Market median
+37% vs market
20222024
Debt / equity
2.66×
This company
0.62×
Market median
-329% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
MB Management | Management | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Former (5) | ||
| Board of Directors | 2024 – 2024 | |
| Chairman | 2024 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2022 – 2024 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Livio Sperm Bank ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mona Berger Håkonsen Bungum | Management | 0 companies |
| Anna Karin Helena Lind | Board of Directors | 0 companies |
| Anna Karolina Anbratt | Board of Directors | 0 companies |
| Eva Anna-Carin Strandberg | Chairman | 0 companies |
| Eugene Maxwell Marsden | Chairman | 0 companies |
| Karl Henrik Hernander | Board of Directors | 0 companies |
| Francisco Jiménez Sirvent | Chairman | 0 companies |
| Håkan Lennart Wramsby | Chairman | 0 companies |